X, G., X, P., J, W., L, Y., Y, C., L, L., . . . Y, W. (2021). Enhancing of Nanocatalyst-Driven Chemodynaminc Therapy for Endometrial Cancer Cells Through Inhibition of PINK1/Parkin-Mediated Mitophagy. Dove Medical Press.
Cita Chicago Style (17a ed.)X, Gong, et al. Enhancing of Nanocatalyst-Driven Chemodynaminc Therapy for Endometrial Cancer Cells Through Inhibition of PINK1/Parkin-Mediated Mitophagy. Dove Medical Press, 2021.
Cita MLA (8a ed.)X, Gong, et al. Enhancing of Nanocatalyst-Driven Chemodynaminc Therapy for Endometrial Cancer Cells Through Inhibition of PINK1/Parkin-Mediated Mitophagy. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.